PaperFirst line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma
References (13)
- et al.
The concentration of radioactivity for labelled epinephrine and its precursors in the dog adrenal medulla
J Nucl Med
(1967) - et al.
Scintigraphic localization of pheochromocytoma
New Engl J Med
(1981) - et al.
Iodine-131 metaiodobenzylguanidine for the location of suspected pheochromocytoma: experience in 400 cases
J NuclMed
(1985) - et al.
Radiopharmaceutical treatment of malignant pheochromocytoma
J Nucl Med
(1984) - et al.
Radionuclide diagnosis and treatment of neural crest tumors using iodine-131-meta-iodobenzylguanidine
J Nucl Med
(1987) - et al.
Mechanisms of uptake of norepinephrine (NE) and meta-iodobenzylguanidine (MIBG) into cultured human pheochromocytoma cells
J Nucl Med
(1984)
There are more references available in the full text version of this article.
Cited by (71)
Targeted alpha and beta radiotherapy: An overview of radiopharmaceutical and clinical aspects
2018, Medecine Nucleaire<sup>131</sup>I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications
2016, Seminars in Nuclear MedicineCitation Excerpt :Multiple investigations have explored ways to increase therapeutic 131I-mIBG efficacy through combinations that enhance norepinephrine transporter (NET) expression.77-90 More recently, 131I-mIBG has been used as a “front-line” therapeutic agent in those without relapsed or recurrent disease in Dutch and Italian neuroblastoma trials as well as a “front-line” agent administered at the end of induction in the COG ANBL09P1 trial.91-96 Figure 11 depicts the time frames and several of the major trials using 131I-mIBG therapy for neuroblastoma; these major trials and their findings are discussed in the subsequent sections.
A systematic review of <sup>131</sup>I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma
2014, European Journal of CancerRadiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma
2008, Nuclear Medicine and BiologyIodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age
2008, European Journal of Cancer
Copyright © 1995 Published by Elsevier Ltd.